Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Investigator- and Subject-Blind, Randomized, Placebo-Controlled, Parallel-Group, Repeat-Dose Study to Evaluate the Effect of CDP7657 in Subjects With Active Systemic Lupus Erythematosus

NCT01764594 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01764594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Investigator- and Subject-Blind, Randomized, Placebo-Controlled, Parallel-Group, Repeat-Dose Study to Evaluate the Effect of CDP7657 in Subjects With Active Systemic Lupus Erythematosus
Lead sponsor
UCB Pharma
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2014
Enrollment
24 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, connective tissue disease, immune system diseases, lupus erythematosus, systemic, skin and connective tissue diseases